Recombinant TRAIL and TRAIL receptor analysis (Q46500389)

22 December 2017

title

Recombinant TRAIL and TRAIL receptor analysis (English)

1 reference

22 December 2017

author name string

Nicholas Harper

series ordinal

1

1 reference

22 December 2017

Marion MacFarlane

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

22 December 2017

published in

Methods in Enzymology

1 reference

22 December 2017

volume

446

1 reference

22 December 2017

page(s)

293-313

1 reference

22 December 2017

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Barriers to effective TRAIL-targeted therapy of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Apo2L/TRAIL and its death and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

The role of receptor internalization in CD95 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

TRAIL-induced signalling and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

An induced proximity model for caspase-8 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

The CD95(APO-1/Fas) DISC and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

A novel domain within the 55 kd TNF receptor signals cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2808%2901618-2

7 January 2021

10.1016/S0076-6879(08)01618-2

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017